Similar articles

• [Past, present and future of zidovudine, the first antiretroviral drug].

  Martín Fernández J, Rubio García R, Pulido Ortega F. Martín Fernández J, et al. An Med Interna. 1998 Mar;15(3):163-70. An Med Interna. 1998. PMID: 9567426 Review. Spanish.
• [Zidovudine in asymptomatic HIV infection].

  Bornkessel B. Bornkessel B. Med Monatsschr Pharm. 1991 Aug;14(8):250. Med Monatsschr Pharm. 1991. PMID: 1921844 Clinical Trial. German. No abstract available.
• Late treatment of HIV infection--is it better?

  Hamilton JD. Hamilton JD. Infect Agents Dis. 1992 Jun;1(3):156-62. Infect Agents Dis. 1992. PMID: 1365540 Review. No abstract available.
• The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.

  Bozzette SA, Kanouse DE, Duan N, Berry S, Richman DD. Bozzette SA, et al. Antivir Ther. 1996 Jan;1(1):21-32. Antivir Ther. 1996. PMID: 11322256 Clinical Trial.
• Closing the circle on HIV--or not.

  Mascolini M. Mascolini M. J Int Assoc Physicians AIDS Care. 1995 Oct;1(9):10-4, 17-29 contd. J Int Assoc Physicians AIDS Care. 1995. PMID: 11362964